Fig. 2From: Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s diseaseCSF levels (Z scores) of neurofilament light chain (NfL) (a), fatty acid binding protein 3 (Fabp3) (b), and interleukin (IL)-10 (c) in subjects with normal cognition (NC), mild cognitive impairment (MCI), Alzheimer’s disease (AD) dementia, and other non-AD dementia (OD). (*p < 0.001; †p < 0.005; p < 0.05 for other comparisons indicated). Differences between different subgroups are summarized in d, with direction of change reflecting the stage with more severe pathology or cognitive impairmentBack to article page